Ascletis Pharma Inc. (01672)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Gu Jiong | 27-Apr-18 | INED | |||
| Wu He Judy Jingdao | 30-Mar-18 | 06-Nov-23 | ED | ||
| Chung Ming Fai | 22-Aug-22 | 20-Sep-22 | CoSec | ||
| Hua Lin | 27-Apr-18 | 20-Sep-22 | INED | ||
| Wu Jason Jinzi | 25-Feb-14 | 20-Sep-22 | CEO | ||
| Yim Issac Lok Kwan | 04-Jun-18 | 22-Aug-22 | CoSec | ||
| Yim Lok Kwan | 22-Aug-22 | CoSec | No reasons provided | ||
| Wu Jason Jinzi | 25-Feb-14 | 08-Jun-22 | Fdr | ||
| Wu Jason Jinzi | 25-Feb-14 | 13-May-21 | Ch | ||
| Wu He Judy Jingdao | 30-Mar-18 | 13-Jul-20 | VP | ||
| Ji Ru Rong | 27-Apr-18 | 30-Jun-20 | INED | ||
| Wei Yizhen | 27-Apr-18 | 28-May-19 | INED | ||
| Wang Jianjiong | 27-Apr-18 | 13-Mar-19 | CoSec | ||
| Fu Wei | 30-Mar-18 | 24-Dec-18 | Non-Executive Director |